Skip to main content
Top
Published in: Endocrine Pathology 1/2008

01-04-2008

ACTH and α-Subunit are Co-expressed in Rare Human Pituitary Corticotroph Cell Adenomas Proposed to Originate from ACTH-Committed Early Pituitary Progenitor Cells

Authors: Masanori Suzuki, Noboru Egashira, Hanako Kajiya, Takeo Minematsu, Susumu Takekoshi, Shigeyuki Tahara, Naoko Sanno, Akira Teramoto, Robert Yoshiyuki Osamura

Published in: Endocrine Pathology | Issue 1/2008

Login to get access

Abstract

The functional differentiation of pituitary cells and adenomas follows the combination of transcription factors and co-factors in three cell lineages [growth hormone–prolactin–thyroid-stimulating hormone lineage, adrenocorticotrophic hormone (ACTH)/pro-opiomelanocortin (POMC) lineage, and follicular stimulating hormone (FSH)/luteinizing hormone (LH) lineage], which include Pit-1, GATA-2, SF-1, NeuroD1/beta2, Tpit, ERα, and others. Only rarely are hormones from different lineages co-expressed in the same adenoma cells. Most corticotroph cell adenomas belonging to the ACTH/POMC lineage are mono-hormonal. In our study of 89 corticotroph cell adenomas, 5 cases expressed both ACTH and alpha-subunit; these adenomas did not express any other anterior pituitary hormones or subunits. To clarify the mechanism involved, we studied the transcription factors that regulate pituitary cell differentiation. NeuroD1 and T-pit, markers of the ACTH/POMC lineage, and SF-1 and DAX-1, related to the LH/FSH cell lineage were expressed in all cases. GATA2, a synergistic factor in the gonadotroph cell lineage with SF-1, was also expressed in three of five cases. As ACTH and alpha-subunit are the earliest hormones to appear during development, we speculate that these particular adenomas are derived from committed ACTH progenitor cells. The molecular process governing functional differentiation of these adenomas requires further investigation.
Literature
1.
go back to reference Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81:2165–70, 1996.PubMedCrossRef Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S. The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81:2165–70, 1996.PubMedCrossRef
2.
go back to reference Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77:1275–80, 1993.PubMedCrossRef Asa SL, Puy LA, Lew AM, Sundmark VC, Elsholtz HP. Cell type-specific expression of the pituitary transcription activator pit-1 in the human pituitary and pituitary adenomas. J Clin Endocrinol Metab 77:1275–80, 1993.PubMedCrossRef
3.
go back to reference Aylwin SJ, Welch JP, Davey CL, Geddes JF, Wood DF, Besser GM, et al. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. J Clin Endocrinol Metab 86:2476–83, 2001.PubMedCrossRef Aylwin SJ, Welch JP, Davey CL, Geddes JF, Wood DF, Besser GM, et al. The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas. J Clin Endocrinol Metab 86:2476–83, 2001.PubMedCrossRef
4.
go back to reference Ferretti E, Di Stefano D, Zazzeroni F, Gallo R, Fratticci A, Carfagnini R, et al. Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. J Endocrinol Invest 26:957–65, 2003.PubMed Ferretti E, Di Stefano D, Zazzeroni F, Gallo R, Fratticci A, Carfagnini R, et al. Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1. J Endocrinol Invest 26:957–65, 2003.PubMed
5.
go back to reference Friend KE, Chiou YK, Lopes MB, Laws ER Jr, Hughes KM, Shupnik MA. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:1497–504, 1994.PubMedCrossRef Friend KE, Chiou YK, Lopes MB, Laws ER Jr, Hughes KM, Shupnik MA. Estrogen receptor expression in human pituitary: correlation with immunohistochemistry in normal tissue, and immunohistochemistry and morphology in macroadenomas. J Clin Endocrinol Metab 78:1497–504, 1994.PubMedCrossRef
6.
go back to reference Ikuyama S, Mu YM, Ohe K, Nakagaki H, Fukushima T, Takayanagi R, et al. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas. Clin Endocrinol (Oxf) 48:647–54, 1998.CrossRef Ikuyama S, Mu YM, Ohe K, Nakagaki H, Fukushima T, Takayanagi R, et al. Expression of an orphan nuclear receptor DAX-1 in human pituitary adenomas. Clin Endocrinol (Oxf) 48:647–54, 1998.CrossRef
7.
go back to reference La Rosa S, Celato N, Uccella S, Capella C. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. Virchows Arch 437:264–9, 2000.PubMedCrossRef La Rosa S, Celato N, Uccella S, Capella C. Detection of gonadotropin-releasing hormone receptor in normal human pituitary cells and pituitary adenomas using immunohistochemistry. Virchows Arch 437:264–9, 2000.PubMedCrossRef
8.
go back to reference Lamolet B, Poulin G, Chu K, Guillemot F, Tsai MJ, Drouin J. Tpit-independent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Mol Endocrinol 18:995–1003, 2004.PubMedCrossRef Lamolet B, Poulin G, Chu K, Guillemot F, Tsai MJ, Drouin J. Tpit-independent function of NeuroD1(BETA2) in pituitary corticotroph differentiation. Mol Endocrinol 18:995–1003, 2004.PubMedCrossRef
9.
go back to reference Matsuno A, Katakami H, Nagashima T, Teramoto A, Osamura RY, Kirino T. Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system. Hum Pathol 31:789–94, 2000.PubMedCrossRef Matsuno A, Katakami H, Nagashima T, Teramoto A, Osamura RY, Kirino T. Growth hormone-releasing hormone expression in pituitary somatotroph adenomas, studied by immunohistochemistry and in situ hybridization using catalyzed signal amplification system. Hum Pathol 31:789–94, 2000.PubMedCrossRef
10.
go back to reference Miller GM, Alexander JM, Klibanski A. Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary. J Clin Endocrinol Metab 81:80–3, 1996.PubMedCrossRef Miller GM, Alexander JM, Klibanski A. Gonadotropin-releasing hormone messenger RNA expression in gonadotroph tumors and normal human pituitary. J Clin Endocrinol Metab 81:80–3, 1996.PubMedCrossRef
11.
go back to reference Oyama K, Sanno N, Teramoto A, Osamura RY. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Mod Pathol 14:892–9, 2001.PubMedCrossRef Oyama K, Sanno N, Teramoto A, Osamura RY. Expression of neuro D1 in human normal pituitaries and pituitary adenomas. Mod Pathol 14:892–9, 2001.PubMedCrossRef
12.
go back to reference Sanno N, Teramoto A, Matsuno A, Itoh J, Takekoshi S, Osamura RY. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas. Acta Neuropathol (Berl) 91:263–8, 1996.CrossRef Sanno N, Teramoto A, Matsuno A, Itoh J, Takekoshi S, Osamura RY. In situ hybridization analysis of Pit-1 mRNA and hormonal production in human pituitary adenomas. Acta Neuropathol (Berl) 91:263–8, 1996.CrossRef
13.
go back to reference Umeoka K, Sanno N, Osamura RY, Teramoto A. Expression of GATA-2 in human pituitary adenomas. Mod Pathol 15:11–7, 2002.PubMedCrossRef Umeoka K, Sanno N, Osamura RY, Teramoto A. Expression of GATA-2 in human pituitary adenomas. Mod Pathol 15:11–7, 2002.PubMedCrossRef
14.
go back to reference Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80:3621–7, 1995.PubMedCrossRef Zafar M, Ezzat S, Ramyar L, Pan N, Smyth HS, Asa SL. Cell-specific expression of estrogen receptor in the human pituitary and its adenomas. J Clin Endocrinol Metab 80:3621–7, 1995.PubMedCrossRef
15.
go back to reference Osamura RY, Watanabe K. Immunohistochemical studies of human FSH producing pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 413:61–8, 1988.PubMedCrossRef Osamura RY, Watanabe K. Immunohistochemical studies of human FSH producing pituitary adenomas. Virchows Arch A Pathol Anat Histopathol 413:61–8, 1988.PubMedCrossRef
16.
go back to reference Sano T, Kovacs K, Asa SL, Smyth HS. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Virchows Arch A Pathol Anat Histopathol 417:361–7, 1990.PubMedCrossRef Sano T, Kovacs K, Asa SL, Smyth HS. Immunoreactive luteinizing hormone in functioning corticotroph adenomas of the pituitary. Immunohistochemical and tissue culture studies of two cases. Virchows Arch A Pathol Anat Histopathol 417:361–7, 1990.PubMedCrossRef
17.
go back to reference Egensperger R, Scheithauer BW, Horvath E, Kovacs K, Giannini C, Young WF, et al. Cushing’s disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenoma. Acta Neuropathol (Berl) 102:398–403, 2001. Egensperger R, Scheithauer BW, Horvath E, Kovacs K, Giannini C, Young WF, et al. Cushing’s disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenoma. Acta Neuropathol (Berl) 102:398–403, 2001.
18.
go back to reference Ikeda H, Yoshimoto T, Kovacs K, Horvath E. Cushing’s disease due to female gonadotroph adenoma of the pituitary. Clin Endocrinol (Oxf) 43:383–6, 1995.CrossRef Ikeda H, Yoshimoto T, Kovacs K, Horvath E. Cushing’s disease due to female gonadotroph adenoma of the pituitary. Clin Endocrinol (Oxf) 43:383–6, 1995.CrossRef
19.
go back to reference Osamura RY. Functional prenatal development of anencephalic and normal anterior pituitary glands. In human and experimental animals studied by peroxidase-labeled antibody method. Acta Pathol Jpn 27(4):495–509, 1977.PubMed Osamura RY. Functional prenatal development of anencephalic and normal anterior pituitary glands. In human and experimental animals studied by peroxidase-labeled antibody method. Acta Pathol Jpn 27(4):495–509, 1977.PubMed
20.
go back to reference Asa SL, Kavacs K, Laszlo FA, Domokos I, Ezrin C. Human fetal adenohypophysis histogeic and immunocytochemical analysis. Neuroendocrinology 43(3):308–16, 1986.PubMedCrossRef Asa SL, Kavacs K, Laszlo FA, Domokos I, Ezrin C. Human fetal adenohypophysis histogeic and immunocytochemical analysis. Neuroendocrinology 43(3):308–16, 1986.PubMedCrossRef
21.
go back to reference Berg KK, Scheithauer BW, Felix I, Kovacs K, Horvath E, Klee GG, et al. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases. Neurosurgery 26:397–403, 1990.PubMedCrossRef Berg KK, Scheithauer BW, Felix I, Kovacs K, Horvath E, Klee GG, et al. Pituitary adenomas that produce adrenocorticotropic hormone and alpha-subunit: clinicopathological, immunohistochemical, ultrastructural, and immunoelectron microscopic studies in nine cases. Neurosurgery 26:397–403, 1990.PubMedCrossRef
22.
go back to reference Desai B, Burrin JM, Nott CA, Geddes JF, Lamb EJ, Aylwin SJ, et al. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours—an in vitro and immunohistochemical study. Eur J Endocrinol 133:25–32, 1995.PubMedCrossRef Desai B, Burrin JM, Nott CA, Geddes JF, Lamb EJ, Aylwin SJ, et al. Glycoprotein hormone alpha-subunit production and plurihormonality in human corticotroph tumours—an in vitro and immunohistochemical study. Eur J Endocrinol 133:25–32, 1995.PubMedCrossRef
23.
go back to reference Osamura RY, Watanabe K. Immunohistochemical colocalization of growth hormone (GH) and α subunit in human GH secreting pituitary adenomas. Virchows Archiv A 411:323–30, 1987.CrossRef Osamura RY, Watanabe K. Immunohistochemical colocalization of growth hormone (GH) and α subunit in human GH secreting pituitary adenomas. Virchows Archiv A 411:323–30, 1987.CrossRef
24.
go back to reference Xu B, Sano A, Yamada S, Li CC, Hirokawa M. Expression of corticotrophin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential. J Clin Endocrinol Metab 85(3):1220–5, 2000.PubMedCrossRef Xu B, Sano A, Yamada S, Li CC, Hirokawa M. Expression of corticotrophin-releasing hormone messenger ribonucleic acid in human pituitary corticotroph adenomas associated with proliferative potential. J Clin Endocrinol Metab 85(3):1220–5, 2000.PubMedCrossRef
25.
go back to reference Losa M, Barzanghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas. Am J Pathol 156(1):245–51, 2000.PubMed Losa M, Barzanghi RL, Mortini P, Franzin A, Mangili F, Terreni MR, et al. Determination of the proliferation and apoptotic index in adrenocorticotropin-secreting pituitary tumors: comparison between micro- and macroadenomas. Am J Pathol 156(1):245–51, 2000.PubMed
26.
go back to reference Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Ruggeri A, et al. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody. Tumori 86(3):229–32, 2000.PubMed Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Ruggeri A, et al. Adrenocorticotropic hormone secreting pituitary adenomas: analysis of growth fraction using the MIB-1 antibody. Tumori 86(3):229–32, 2000.PubMed
27.
go back to reference Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52(2):107–11, 1999.PubMed Mastronardi L, Guiducci A, Spera C, Puzzilli F, Liberati F, Maira G. Ki-67 labelling index and invasiveness among anterior pituitary adenomas: analysis of 103 cases using the MIB-1 monoclonal antibody. J Clin Pathol 52(2):107–11, 1999.PubMed
28.
go back to reference Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Osamura RY. A case of Cushing’s disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol 15(10):1102–5, 2002.PubMedCrossRef Tahara S, Kurotani R, Ishii Y, Sanno N, Teramoto A, Osamura RY. A case of Cushing’s disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism. Mod Pathol 15(10):1102–5, 2002.PubMedCrossRef
29.
go back to reference Kurotani R, Yoshimura S, Iwasaki Y, Inoue K, Teramoto A, Osamura RY. Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. J Endocrinol 172:477–87, 2002.PubMedCrossRef Kurotani R, Yoshimura S, Iwasaki Y, Inoue K, Teramoto A, Osamura RY. Exogenous expression of Pit-1 in AtT-20 corticotropic cells induces endogenous growth hormone gene transcription. J Endocrinol 172:477–87, 2002.PubMedCrossRef
30.
go back to reference Barnhart KM, Mellon PL. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 8:878–85, 1994.PubMedCrossRef Barnhart KM, Mellon PL. The orphan nuclear receptor, steroidogenic factor-1, regulates the glycoprotein hormone alpha-subunit gene in pituitary gonadotropes. Mol Endocrinol 8:878–85, 1994.PubMedCrossRef
31.
go back to reference Osamura RY, Tahara S, Komatsubara K, Itoh Y, Kajiwara H, Kurotani R, et al. Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage? Pituitary 1:269–71, 1999.PubMedCrossRef Osamura RY, Tahara S, Komatsubara K, Itoh Y, Kajiwara H, Kurotani R, et al. Pit-1 positive alpha-subunit positive nonfunctioning human pituitary adenomas: a dedifferentiated GH cell lineage? Pituitary 1:269–71, 1999.PubMedCrossRef
32.
go back to reference Delegeane AM, Ferland LH, Mellon P. Tissue specific enhancer of the human glycoprotein hormone a subunit gene: dependence on cAMP inducible elements. Mol Cell Biol 7:3994–4002, 1987.PubMed Delegeane AM, Ferland LH, Mellon P. Tissue specific enhancer of the human glycoprotein hormone a subunit gene: dependence on cAMP inducible elements. Mol Cell Biol 7:3994–4002, 1987.PubMed
33.
go back to reference Pulichino AM, Vallette Kasic S, Tsai JP, Couture C, Gauthier Y, Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17:738–47, 2003.PubMedCrossRef Pulichino AM, Vallette Kasic S, Tsai JP, Couture C, Gauthier Y, Drouin J. Tpit determines alternate fates during pituitary cell differentiation. Genes Dev 17:738–47, 2003.PubMedCrossRef
34.
go back to reference Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ. Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 265(2):329–40, 2004.PubMedCrossRef Raetzman LT, Ross SA, Cook S, Dunwoodie SL, Camper SA, Thomas PQ. Developmental regulation of Notch signaling genes in the embryonic pituitary: Prop1 deficiency affects Notch2 expression. Dev Biol 265(2):329–40, 2004.PubMedCrossRef
35.
go back to reference Raetzman LT, Wheeler BS, Ross SA, Thomas PQ, Camper SA. Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 20(11):2898–908, 2006.PubMedCrossRef Raetzman LT, Wheeler BS, Ross SA, Thomas PQ, Camper SA. Persistent expression of Notch2 delays gonadotrope differentiation. Mol Endocrinol 20(11):2898–908, 2006.PubMedCrossRef
36.
go back to reference Ishii Y, Suzuki M, Takekoshi S, Egashira N, Yamazaki M, Miyai S, et al. Immunonegative “null cell” adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors. Endocr Pathol 17:35–43, 2006.PubMedCrossRef Ishii Y, Suzuki M, Takekoshi S, Egashira N, Yamazaki M, Miyai S, et al. Immunonegative “null cell” adenomas and gonadotropin (Gn) subunit (SUs) immunopositive adenomas share frequent expression of multiple transcription factors. Endocr Pathol 17:35–43, 2006.PubMedCrossRef
Metadata
Title
ACTH and α-Subunit are Co-expressed in Rare Human Pituitary Corticotroph Cell Adenomas Proposed to Originate from ACTH-Committed Early Pituitary Progenitor Cells
Authors
Masanori Suzuki
Noboru Egashira
Hanako Kajiya
Takeo Minematsu
Susumu Takekoshi
Shigeyuki Tahara
Naoko Sanno
Akira Teramoto
Robert Yoshiyuki Osamura
Publication date
01-04-2008
Publisher
Humana Press Inc
Published in
Endocrine Pathology / Issue 1/2008
Print ISSN: 1046-3976
Electronic ISSN: 1559-0097
DOI
https://doi.org/10.1007/s12022-008-9014-6

Other articles of this Issue 1/2008

Endocrine Pathology 1/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.